Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study

INTRODUCTION: Modus Vivendi was conducted in routine clinical practice to evaluate the effect of adding trimetazidine 80 mg once daily (TMZ 80 OD) to treat patients with persistent symptoms despite treatment with background antianginal therapies including maximally tolerated bisoprolol. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopatin, Yuri, Petrova, Parvoleta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933606/
https://www.ncbi.nlm.nih.gov/pubmed/34958427
http://dx.doi.org/10.1007/s40119-021-00249-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933606/
https://www.ncbi.nlm.nih.gov/pubmed/34958427
http://dx.doi.org/10.1007/s40119-021-00249-z

Ejemplares similares